British Journal of Cancer - Table of Contents alert Volume 106 Issue 9

TABLE OF CONTENTS Volume 106, Issue 9 (1467-1580) Published online 24 April 2012 In this issue Editorial Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letter to the Editor Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Hot off the press!! Did you know this article from British Journal of Cancer recently appeared in the press? Variation in advanced stage at diagnosis of lung and female breast cancer in an English region 2006-2009 G Lyratzopoulos, G A Abel et al Read this Article now!   Editorial Top Gamma-glutamyl transferase: risk and prognosis of cancer I S Fentiman Br J Cancer 2012 106: 1467-1468; 10.1038/bjc.2012.128 Full Text Clinical Studies Top Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum J H Yi, J Lee, J Lee, S H Park, J O Park, D-S Yim, Y S Park, H Y Lim and W K Kang Br J Cancer 2012 106: 1469-1474; advance online publication, March 29, 2012; 10.1038/bjc.2012.100 Abstract | Full Text Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis S Bracarda, T E Hutson, C Porta, R A Figlin, E Calvo, V Grünwald, A Ravaud, R Motzer, D Kim, O Anak, A Panneerselvam and B Escudier Br J Cancer 2012 106: 1475-1480; advance online publication, March 22, 2012; 10.1038/bjc.2012.89 Abstract | Full Text Translational Therapeutics Top Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase L G Feun, A Marini, G Walker, G Elgart, F Moffat, S E Rodgers, C J Wu, M You, M Wangpaichitr, M T Kuo, W Sisson, A A Jungbluth, J Bomalaski and N Savaraj Br J Cancer 2012 106: 1481-1485; advance online publication, April 3, 2012; 10.1038/bjc.2012.106 Abstract | Full Text PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice B Shen, E S H Chu, G Zhao, K Man, C-W Wu, J T Y Cheng, G Li, Y Nie, C M Lo, N Teoh, G C Farrell, J J Y Sung and J Yu Br J Cancer 2012 106: 1486-1494; advance online publication, April 3, 2012; 10.1038/bjc.2012.130 Abstract | Full Text Molecular Diagnostics Top MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients A M J Langers, H W Verspaget, L J A C Hawinkels, F J G M Kubben, W van Duijn, J J van der Reijden, J C H Hardwick, D W Hommes and C F M Sier Br J Cancer 2012 106: 1495-1498; advance online publication, April 3, 2012; 10.1038/bjc.2012.80 Abstract | Full Text Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer S Hector, S Conlon, J Schmid, P Dicker, R J Cummins, C G Concannon, P G Johnston, E W Kay and J H M Prehn Br J Cancer 2012 106: 1499-1505; advance online publication, April 5, 2012; 10.1038/bjc.2012.133 Abstract | Full Text Mitochondrial D310 mutations in the early development of breast cancer C Xu, D Tran-Thanh, C Ma, K May, J Jung, J Vecchiarelli and S J Done Br J Cancer 2012 106: 1506-1511; advance online publication, April 3, 2012; 10.1038/bjc.2012.74 Abstract | Full Text Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations G Yang, Y Quan, W Wang, Q Fu, J Wu, T Mei, J Li, Y Tang, C Luo, Q Ouyang, S Chen, L Wu, T K Hei and Y Wang Br J Cancer 2012 106: 1512-1519; advance online publication, April 3, 2012; 10.1038/bjc.2012.126 Abstract | Full Text CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients M Schrevel, R Karim, N T ter Haar, S H van der Burg, J B M Z Trimbos, G J Fleuren, A Gorter and E S Jordanova Br J Cancer 2012 106: 1520-1525; 10.1038/bjc.2012.110 Abstract | Full Text The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer C B Lajer, E Garnæs, L Friis-Hansen, B Norrild, M H Therkildsen, M Glud, M Rossing, H Lajer, D Svane, L Skotte, L Specht, C Buchwald and F C Nielsen Br J Cancer 2012 106: 1526-1534; advance online publication, April 3, 2012; 10.1038/bjc.2012.109 Abstract | Full Text PI3K/Akt signalling is required for the attachment and spreading, and growth in vivo of metastatic scirrhous gastric carcinoma T Matsuoka, M Yashiro, N Nishioka, K Hirakawa, K Olden and J D Roberts Br J Cancer 2012 106: 1535-1542; 10.1038/bjc.2012.107 Abstract | Full Text Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy S Bellone, D Roque, E Cocco, S Gasparrini, I Bortolomai, N Buza, M Abu-Khalaf, D-A Silasi, E Ratner, M Azodi, P E Schwartz, T J Rutherford, S Pecorelli and A D Santin Br J Cancer 2012 106: 1543-1550; 10.1038/bjc.2012.132 Abstract | Full Text Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial V Seebacher, S Polterauer, C Grimm, J Rahhal, G Hofstetter, E-M Bauer, H Husslein, H Leipold, C Marth, A Reinthaller and N Concin Br J Cancer 2012 106: 1551-1555; advance online publication, February 7, 2012; 10.1038/bjc.2012.16 Abstract | Full Text Epidemiology Top Evidence for under-diagnosis of childhood acute lymphoblastic leukaemia in poorer communities within Great Britain M E Kroll, C A Stiller, S Richards, C Mitchell and L M Carpenter Br J Cancer 2012 106: 1556-1559; advance online publication, April 3, 2012; 10.1038/bjc.2012.102 Abstract | Full Text Loss of partner and breast cancer prognosis — a population-based study, Denmark, 1994–2010 M H Olsen, P E Bidstrup, K Frederiksen, N H Rod, M Grønbæk, S O Dalton and C Johansen Br J Cancer 2012 106: 1560-1563; advance online publication, March 20, 2012; 10.1038/bjc.2012.96 Abstract | Full Text Use of Aspirin postdiagnosis improves survival for colon cancer patients E Bastiaannet, K Sampieri, O M Dekkers, A J M de Craen, M P P van Herk-Sukel, V Lemmens, C B M van den Broek, J W Coebergh, R M C Herings, C J H van de Velde, R Fodde and G J Liefers Br J Cancer 2012 106: 1564-1570; advance online publication, March 27, 2012; 10.1038/bjc.2012.101 Abstract | Full Text Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway E A Burger, J D Ortendahl, S Sy, I S Kristiansen and J J Kim Br J Cancer 2012 106: 1571-1578; advance online publication, March 22, 2012; 10.1038/bjc.2012.94 Abstract | Full Text Letter to the Editor Top Personalised cancer follow-up: risk stratification, needs assessment or both? T Filleron, F Dalenc and A Kramar Br J Cancer 2012 106: 1579-1580; advance online publication, April 3, 2012; 10.1038/bjc.2012.108 Full Text Advertisement British Journal of Cancer presents: Web Focus on MicroRNA MicroRNAs have emerged as major new mechanisms of regulation of gene function, potential therapeutic targets, with roles in diagnosis, prognosis and biomarkers. This collection puts MicroRNA in context of other molecular classifications and then investigative articles and reviews cover the main tumour types where microRNAs are emerging as having important roles in biological processes including lung cancer, AML, melanoma, colorectal cancer, nasopharyngeal carcinoma, bladder cancer, rhabdomyosarcoma and heptacellular carcinoma. Read the articles for FREE   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.